Board of Directors
Michael S. Smith became a director in 1995 and assumed the positions of Chairman, President, Chief Executive Officer, and Chief Financial Officer in January 2003. Before joining IGI, Mr. Smith financed, founded, and served as the president and chief executive officer of Micropub Systems International, Inc., a brewery system manufacturer, from July 1997 to January 2003. Mr. Smith has an extensive background in business formation and finance, executive management, investment banking, and securities law. He holds a B.A. degree from Cornell University and a J.D. degree from Cornell University School of Law.
James A. Villa became a director in July 2008 and is a member of the audit and compensation committees. Mr. Villa is the President of Intelligent Consulting Corporation (ICC). ICC provides business consulting services to public and privately held middle market companies including IGI since January 2003. Key services include business mergers and acquisition advice and transaction structuring, strategic business plan development and implementation, personnel recruiting, and management consulting. Mr. Villa has over 25 years experience in finance and investment banking. He holds a B.S. degree in Electrical Engineering from Clarkson University.
Dr. Allan M. Robbins became a director in April 2003 and is a member of the audit and compensation committees. Dr. Robbins is the Medical Director and Chief Surgeon at Robbins Eye Associates and Robbins Laser Site in Rochester, New York. He has also served as the CEO of the Genesee Valley Eye Institute. Dr. Robbins is a board-certified ophthalmologist and completed his fellowship training at the University of Rochester. He has been recognized and received the AMA Commendation for Continuing Medical Education as well as the America’s Top Ophthalmologists 2002-2003 Award from the Consumers Research Council of America. Dr. Robbins is a member of the New York State Medical Society, New York State Ophthalmologist Society, American Academy of Ophthalmology, American College of Surgeons, International Society of Refractive Surgery (ISRS), and the American Society of Cataract and Refractive Surgery (ASCRS). He was on the Scientific Advisory Council for Phoenix Laser and a principal clinical investigator for the VISX laser during the FDA clinical trials.